Updated: November 17, 2026
If you want to know how science is progressing on reversing human aging, you have come to the right place! This curated database charts the progress of promising rejuvenation therapies organized by the 12 hallmarks of aging (the reasons we age). Check out our topic on the clinical trial phases to learn what each phase means.
Roadmap Inclusion Criteria:
- Regulated Therapeutics Only: Covers small molecules, biologics, gene therapies, cell therapies, and clinical medical devices—excluding over-the-counter dietary supplements and cosmetics.
- Commercial Path to Market: Tracks proprietary candidates actively developed by a biotech or pharmaceutical sponsor, excluding off-patent generic academic pilot studies.
- Major Regulatory Oversight: Requires formal clinical trials under recognized agencies (such as the FDA, EMA, or MHRA). Therapies offered exclusively through offshore special economic zones or medical-tourism clinics are excluded, as they bypass rigorous safety standards and prevent broad, equitable public access.
Special thanks to Karl Pfleger at AgingBiotech.info, whose therapy database helped to inform this roadmap.

Loading ...